Full Description
This puts a keen focus on the role of imaging and the need to clearly identify and understand this aspect of clinical trials.
As the pharmaceutical, biotech and medical device industry continues to identify ways to improve and speed up product development, medical imaging plays a more significant role.
Contents
Part I: Overview and Trial Management.- 1. Medical Imaging Modalities.- 2. The Metrics and New Imaging Marker Qualification in Medical Imaging Modalities.- 3. Radiation Risks and Dosimetry Assessment.- 4. Imaging Review Charters and Operational Considerations.- 5. Defining the Radiological Blinded Read and Adjudication.- 6. Medical Imaging in Drug Development.- 7. Evaluating and Working with an Imaging Core Laboratory.- Part II: Therapeutic Specifics of Medical Imaging.- 8. Monitoring Responses to Therapy in Oncology.- 9. Cardiac Imaging in Clinical Trials.- 10. Neuroimaging in Clinical Trials.- 11. Imaging in Musculoskeletal, Metabolic, Endocrinological, and Pediatric Clinical Trials.- 12. Body Composition.- 13. Optical Coherence Tomography as a Biomarker in Clinical Trials for Ophthalmology and Neurology.- 14. Nuclear Medicine: An Overview of Imaging Techniques, Clinical Applications, and Trials.- 15. Contrast Agents in Radiology.- Part III: The Future of Imaging in Clinical Trials.- 16. Pharmaceutical Industry Perspective Regarding Imaging Techniques.
